Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 4/2012

01-12-2012 | Review Article

Nutritional Status and Nutritional Support Before and After Pancreatectomy for Pancreatic Cancer and Chronic Pancreatitis

Authors: Vasiliki Th. Karagianni, Apostolos E. Papalois, John K. Triantafillidis

Published in: Indian Journal of Surgical Oncology | Issue 4/2012

Login to get access

Abstract

Cachexia, malnutrition, significant weight loss, and reduction in food intake due to anorexia represent the most important pathophysiological consequences of pancreatic cancer. Pathophysiological consequences result also from pancreatectomy, the type and severity of which differ significantly and depend on the type of the operation performed. Nutritional intervention, either parenteral or enteral, needs to be seen as a method of support in pancreatic cancer patients aiming at the maintenance of the nutritional and functional status and the prevention or attenuation of cachexia. Oral nutrition could reduce complications while restoring quality of life. Enteral nutrition in the post-operative period could also reduce infective complications. The evidence for immune-enhanced feed in patients undergoing pancreaticoduodenectomy for pancreatic cancer is supported by the available clinical data. Nutritional support during the post-operative period on a cyclical basis is preferred because it is associated with low incidence of gastric stasis. Postoperative total parenteral nutrition is indicated only to those patients who are unable to be fed orally or enterally. Thus nutritional deficiency is a relatively widesoread and constant finding suggesting that we must optimise the nutritional status both before and after surgery.
Literature
1.
go back to reference Rocha-Lima CM (2008) New directions in the management of advanced pancreatic cancer: a review. Anticancer Drugs 19:435–446PubMedCrossRef Rocha-Lima CM (2008) New directions in the management of advanced pancreatic cancer: a review. Anticancer Drugs 19:435–446PubMedCrossRef
2.
go back to reference Bozzetti F (2009) Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17:279–284PubMedCrossRef Bozzetti F (2009) Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17:279–284PubMedCrossRef
3.
go back to reference Ockenga J, Valentini L (2005) Review article: anorexia and cachexia in gastrointestinal cancer. Aliment Pharmacol Ther 22:583–594PubMedCrossRef Ockenga J, Valentini L (2005) Review article: anorexia and cachexia in gastrointestinal cancer. Aliment Pharmacol Ther 22:583–594PubMedCrossRef
4.
go back to reference Uomo G, Gallucci F, Rabitti PG (2006) Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management. JOP 7:157–162PubMed Uomo G, Gallucci F, Rabitti PG (2006) Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management. JOP 7:157–162PubMed
5.
go back to reference Di Luzio R, Moscatiello S, Marchesini G (2010) Role of nutrition in gastrointestinal oncological patients. Eur Rev Med Pharmacol Sci 14:277–284PubMed Di Luzio R, Moscatiello S, Marchesini G (2010) Role of nutrition in gastrointestinal oncological patients. Eur Rev Med Pharmacol Sci 14:277–284PubMed
6.
go back to reference Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12:1193–1201PubMedCrossRef Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12:1193–1201PubMedCrossRef
7.
go back to reference Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2009) Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 9:255PubMedCrossRef Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2009) Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 9:255PubMedCrossRef
8.
go back to reference Raghu Dhanapal R, Saraswathi TR, Rajkumar N, Govind RN (2011) Cancer cachexia. J Oral Maxillofac Pathol 15:257–260PubMedCrossRef Raghu Dhanapal R, Saraswathi TR, Rajkumar N, Govind RN (2011) Cancer cachexia. J Oral Maxillofac Pathol 15:257–260PubMedCrossRef
9.
go back to reference Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM (2004) Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 7:427–434PubMedCrossRef Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM (2004) Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 7:427–434PubMedCrossRef
10.
go back to reference Legakis I, Stathopoulos J, Matzouridis T, Stathopoulos GP (2009) Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals. Anticancer Res 29:3949–3952PubMed Legakis I, Stathopoulos J, Matzouridis T, Stathopoulos GP (2009) Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals. Anticancer Res 29:3949–3952PubMed
11.
go back to reference Banks WA (2001) Anorectic effects of calculating cytokines: role of the vascular blood-brain barrier. Nutrition 17:434–437PubMedCrossRef Banks WA (2001) Anorectic effects of calculating cytokines: role of the vascular blood-brain barrier. Nutrition 17:434–437PubMedCrossRef
12.
go back to reference Karayiannakis AJ, Syrigos KN, Polychronidis A, Pitiakoudis M, Bounovas A, Simopoulos K (2001) Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients. Anticancer Res 21(2B):1355–1358PubMed Karayiannakis AJ, Syrigos KN, Polychronidis A, Pitiakoudis M, Bounovas A, Simopoulos K (2001) Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients. Anticancer Res 21(2B):1355–1358PubMed
13.
go back to reference Argilés JM, Busquets S, García-Martínez C, López-Soriano FJ (2005) Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future. Nutrition 21:977–985PubMedCrossRef Argilés JM, Busquets S, García-Martínez C, López-Soriano FJ (2005) Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future. Nutrition 21:977–985PubMedCrossRef
14.
go back to reference Durham WJ, Dillon EL, Sheffield-Moore M (2009) Inflammatory burden and amino acid metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care 12:72–77PubMedCrossRef Durham WJ, Dillon EL, Sheffield-Moore M (2009) Inflammatory burden and amino acid metabolism in cancer cachexia. Curr Opin Clin Nutr Metab Care 12:72–77PubMedCrossRef
16.
go back to reference Coss CC, Bohl CE, Dalton JT (2011) Cancer cachexia therapy: a key weapon in the fight against cancer. Curr Opin Clin Nutr Metab Care 14:268–273PubMedCrossRef Coss CC, Bohl CE, Dalton JT (2011) Cancer cachexia therapy: a key weapon in the fight against cancer. Curr Opin Clin Nutr Metab Care 14:268–273PubMedCrossRef
17.
go back to reference Takaki M (2003) Gut pacemaker cells: the intestinal cells of Cajal (ICC). J Smooth Muscle Res 39:137–161PubMedCrossRef Takaki M (2003) Gut pacemaker cells: the intestinal cells of Cajal (ICC). J Smooth Muscle Res 39:137–161PubMedCrossRef
18.
go back to reference Martignoni ME, Friess H, Sell F, Ricken L, Shrikhande S, Kulli C, Büchler MW (2000) Enteral nutrition prolongs delayed gastric emptying in patients after Whipple resection. Am J Surg 180:18–23PubMedCrossRef Martignoni ME, Friess H, Sell F, Ricken L, Shrikhande S, Kulli C, Büchler MW (2000) Enteral nutrition prolongs delayed gastric emptying in patients after Whipple resection. Am J Surg 180:18–23PubMedCrossRef
19.
go back to reference Ishikawa O (1996) Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepatogastroenterology 43:320–325PubMed Ishikawa O (1996) Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepatogastroenterology 43:320–325PubMed
20.
go back to reference Chang EB (1986) Experimental diabetic diarrhea in rats. Intestinal mucosal denervation hypersensitivity and therapy with clonidine. Gastroenterology 91:564–569PubMed Chang EB (1986) Experimental diabetic diarrhea in rats. Intestinal mucosal denervation hypersensitivity and therapy with clonidine. Gastroenterology 91:564–569PubMed
21.
go back to reference Chang EB, Bergenstal RM, Field M (1985) Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport. J Clin Invest 75:1666–1670PubMedCrossRef Chang EB, Bergenstal RM, Field M (1985) Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport. J Clin Invest 75:1666–1670PubMedCrossRef
22.
go back to reference Pappas S, Krzywda E, McDowell N (2010) Nutrition and pancreaticoduodenectomy. Nutr Clin Pract 25:234–243PubMedCrossRef Pappas S, Krzywda E, McDowell N (2010) Nutrition and pancreaticoduodenectomy. Nutr Clin Pract 25:234–243PubMedCrossRef
23.
go back to reference Seeman E, Melton U III, O’Fallon WM, Riggs BL (1983) Risk factors for spinal osteoporosis in men. Am J Med 75:977–983PubMedCrossRef Seeman E, Melton U III, O’Fallon WM, Riggs BL (1983) Risk factors for spinal osteoporosis in men. Am J Med 75:977–983PubMedCrossRef
24.
go back to reference Bajorunas DR, Fortner JG, Jaspan J, Sherwin RS (1986) Total pancreatectomy increases the metabolic response to glucagon in humans. J Clin Endocrinol Metab 63:439–446PubMedCrossRef Bajorunas DR, Fortner JG, Jaspan J, Sherwin RS (1986) Total pancreatectomy increases the metabolic response to glucagon in humans. J Clin Endocrinol Metab 63:439–446PubMedCrossRef
25.
26.
go back to reference Del Prato S, Tiengo A, Baccaglini U et al (1983) Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Diabetologia 25:252–259PubMedCrossRef Del Prato S, Tiengo A, Baccaglini U et al (1983) Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Diabetologia 25:252–259PubMedCrossRef
27.
go back to reference Jarvinen HY, Kiviluoto T, Taskinen MR (1986) Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism 35:718–727CrossRef Jarvinen HY, Kiviluoto T, Taskinen MR (1986) Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism 35:718–727CrossRef
28.
go back to reference Bajorunas DR, Dresler CM, Horowitz GD et al (1986) Basal glucagon replacement in chronic glucagon deficiency increases insulin resistance. Diabetes 35:556–562PubMedCrossRef Bajorunas DR, Dresler CM, Horowitz GD et al (1986) Basal glucagon replacement in chronic glucagon deficiency increases insulin resistance. Diabetes 35:556–562PubMedCrossRef
29.
go back to reference Bajorunas DR, Fortner JG, Jaspan JB (1986) Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans: paradoxical response to oral glucose. Diabetes 35:886–893PubMedCrossRef Bajorunas DR, Fortner JG, Jaspan JB (1986) Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans: paradoxical response to oral glucose. Diabetes 35:886–893PubMedCrossRef
30.
go back to reference Bennett LL (1983) What causes fatty liver after pancreatectomy-an unresolved and forgotten controversy? Perspect Biol Med 26:595–612PubMed Bennett LL (1983) What causes fatty liver after pancreatectomy-an unresolved and forgotten controversy? Perspect Biol Med 26:595–612PubMed
31.
go back to reference Kunze WA, Furness JB (1999) The enteric nervous system and regulation of intestinal motility. Annu Rev Physiol 61:117–142PubMedCrossRef Kunze WA, Furness JB (1999) The enteric nervous system and regulation of intestinal motility. Annu Rev Physiol 61:117–142PubMedCrossRef
32.
go back to reference Van Citters GW, Lin HC (2006) Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 8:367–373PubMedCrossRef Van Citters GW, Lin HC (2006) Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep 8:367–373PubMedCrossRef
33.
go back to reference Naruse S, Kitagawa M, Ishiguro H et al (2002) Feedback regulation of pancreatic secretion by peptide YY. Peptides 23:359–365PubMedCrossRef Naruse S, Kitagawa M, Ishiguro H et al (2002) Feedback regulation of pancreatic secretion by peptide YY. Peptides 23:359–365PubMedCrossRef
34.
go back to reference Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J (2010) Postoperative bowel function and nutritional status following distal pancreatectomy with en-bloc celiac axis resection. Dig Surg 27:212–216PubMedCrossRef Hirano S, Kondo S, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J (2010) Postoperative bowel function and nutritional status following distal pancreatectomy with en-bloc celiac axis resection. Dig Surg 27:212–216PubMedCrossRef
35.
go back to reference Shikano T, Nakao A, Kodera Y, Yamada S, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Takeda S (2010) Middle pancreatectomy: safety and long-term results. Surgery 147:21–29PubMedCrossRef Shikano T, Nakao A, Kodera Y, Yamada S, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Takeda S (2010) Middle pancreatectomy: safety and long-term results. Surgery 147:21–29PubMedCrossRef
36.
go back to reference Jang JY, Kim SW, Han JK, Park SJ, Park YC, Joon Ahn Y, Park YH (2003) Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans. Ann Surg 237:522–529PubMed Jang JY, Kim SW, Han JK, Park SJ, Park YC, Joon Ahn Y, Park YH (2003) Randomized prospective trial of the effect of induced hypergastrinemia on the prevention of pancreatic atrophy after pancreatoduodenectomy in humans. Ann Surg 237:522–529PubMed
37.
go back to reference Sugiyama M, Atomi Y (2000) Pylorus-preserving total pancreatectomy for pancreatic cancer. World J Surg 24:66–70PubMedCrossRef Sugiyama M, Atomi Y (2000) Pylorus-preserving total pancreatectomy for pancreatic cancer. World J Surg 24:66–70PubMedCrossRef
38.
go back to reference Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Uchiyama K, Yamaue H (2011) Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy. Ann Surg 253:495–501PubMedCrossRef Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A, Uchiyama K, Yamaue H (2011) Pylorus ring resection reduces delayed gastric emptying in patients undergoing pancreatoduodenectomy: a prospective, randomized, controlled trial of pylorus-resecting versus pylorus-preserving pancreatoduodenectomy. Ann Surg 253:495–501PubMedCrossRef
39.
go back to reference Witzigmann H, Max D, Uhlmann D, Geissler F, Schwarz R, Ludwig S, Lohmann T, Caca K, Keim V, Tannapfel A, Hauss J (2003) Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery 134:53–62PubMedCrossRef Witzigmann H, Max D, Uhlmann D, Geissler F, Schwarz R, Ludwig S, Lohmann T, Caca K, Keim V, Tannapfel A, Hauss J (2003) Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery 134:53–62PubMedCrossRef
40.
go back to reference Schnelldorfer T, Adams DB (2005) The effect of malnutrition on morbidity after surgery for chronic pancreatitis. Am Surg 71:466–472PubMed Schnelldorfer T, Adams DB (2005) The effect of malnutrition on morbidity after surgery for chronic pancreatitis. Am Surg 71:466–472PubMed
41.
go back to reference Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98:268–274PubMedCrossRef Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98:268–274PubMedCrossRef
42.
go back to reference Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M (2009) ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr 28:445–454PubMedCrossRef Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M (2009) ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr 28:445–454PubMedCrossRef
43.
go back to reference Pelzer U, Arnold D, Gövercin M, Stieler J, Doerken B, Riess H, Oettle H (2010) Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer 10:86PubMedCrossRef Pelzer U, Arnold D, Gövercin M, Stieler J, Doerken B, Riess H, Oettle H (2010) Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study. BMC Cancer 10:86PubMedCrossRef
44.
go back to reference Brennan MF, Pisters PW, Posner M, Quesada O, Shike M (1994) A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg 220:436–441PubMedCrossRef Brennan MF, Pisters PW, Posner M, Quesada O, Shike M (1994) A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg 220:436–441PubMedCrossRef
45.
go back to reference Liu Q, Liu Z, Chen H, Ma L, Liu L, Zhang J, He Y, Chen J, Qian Q (2011) Treatment with growth hormone, somatostatin, and insulin in combination with hypocaloric parenteral nutrition in gastrointestinal cancer patients after surgery. Nutrition 27:633–640PubMedCrossRef Liu Q, Liu Z, Chen H, Ma L, Liu L, Zhang J, He Y, Chen J, Qian Q (2011) Treatment with growth hormone, somatostatin, and insulin in combination with hypocaloric parenteral nutrition in gastrointestinal cancer patients after surgery. Nutrition 27:633–640PubMedCrossRef
46.
go back to reference Di Carlo V, Gianotti L, Balzano G, Zerbi A, Braga M (1999) Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg 16:320–326PubMedCrossRef Di Carlo V, Gianotti L, Balzano G, Zerbi A, Braga M (1999) Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg 16:320–326PubMedCrossRef
47.
go back to reference Baradi H, Walsh RM, Henderson JM, Vogt D, Popovich M (2004) Postoperative jejunal feeding and outcome of pancreaticoduodenectomy. J Gastrointest Surg 8:428–433PubMedCrossRef Baradi H, Walsh RM, Henderson JM, Vogt D, Popovich M (2004) Postoperative jejunal feeding and outcome of pancreaticoduodenectomy. J Gastrointest Surg 8:428–433PubMedCrossRef
48.
go back to reference Giger U, Büchler M, Farhadi J, Berger D, Hüsler J, Schneider H, Krähenbühl S, Krähenbühl L (2007) Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol 14:2798–2806PubMedCrossRef Giger U, Büchler M, Farhadi J, Berger D, Hüsler J, Schneider H, Krähenbühl S, Krähenbühl L (2007) Preoperative immunonutrition suppresses perioperative inflammatory response in patients with major abdominal surgery-a randomized controlled pilot study. Ann Surg Oncol 14:2798–2806PubMedCrossRef
49.
go back to reference Gianotti L, Braga M, Gentilini O, Balzano G, Zerbi A, Di Carlo V (2000) Artificial nutrition after pancreaticoduodenectomy. Pancreas 21:344–351PubMedCrossRef Gianotti L, Braga M, Gentilini O, Balzano G, Zerbi A, Di Carlo V (2000) Artificial nutrition after pancreaticoduodenectomy. Pancreas 21:344–351PubMedCrossRef
50.
go back to reference Barlow R, Price P, Reid TD, Hunt S, Clark GW, Havard TJ, Puntis MC, Lewis WG (2011) Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection. Clin Nutr 30:560–566PubMedCrossRef Barlow R, Price P, Reid TD, Hunt S, Clark GW, Havard TJ, Puntis MC, Lewis WG (2011) Prospective multicentre randomised controlled trial of early enteral nutrition for patients undergoing major upper gastrointestinal surgical resection. Clin Nutr 30:560–566PubMedCrossRef
51.
go back to reference Klek S, Sierzega M, Szybinski P, Szczepanek K, Scislo L, Walewska E, Kulig J (2011) The immunomodulating enteral nutrition in malnourished surgical patients - a prospective, randomized, double-blind clinical trial. Clin Nutr 30:282–288PubMedCrossRef Klek S, Sierzega M, Szybinski P, Szczepanek K, Scislo L, Walewska E, Kulig J (2011) The immunomodulating enteral nutrition in malnourished surgical patients - a prospective, randomized, double-blind clinical trial. Clin Nutr 30:282–288PubMedCrossRef
52.
go back to reference Klek S, Kulig J, Sierzega M, Szczepanek K, Szybiński P, Scislo L, Walewska E, Kubisz A, Szczepanik AM (2008) Standard and immunomodulating enteral nutrition in patients after extended gastrointestinal surgery–a prospective, randomized, controlled clinical trial. Clin Nutr 27:504–512PubMedCrossRef Klek S, Kulig J, Sierzega M, Szczepanek K, Szybiński P, Scislo L, Walewska E, Kubisz A, Szczepanik AM (2008) Standard and immunomodulating enteral nutrition in patients after extended gastrointestinal surgery–a prospective, randomized, controlled clinical trial. Clin Nutr 27:504–512PubMedCrossRef
53.
go back to reference Paccagnella A, Morassutti I, Rosti G (2011) Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol 23:322–330PubMedCrossRef Paccagnella A, Morassutti I, Rosti G (2011) Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol 23:322–330PubMedCrossRef
54.
go back to reference Wang X, Pan L, Zhang P, Liu X, Wu G, Wang Y, Liu Y, Li N, Li J (2010) Enteral nutrition improves clinical outcome and shortens hospital stay after cancer surgery. J Invest Surg 23:309–313PubMedCrossRef Wang X, Pan L, Zhang P, Liu X, Wu G, Wang Y, Liu Y, Li N, Li J (2010) Enteral nutrition improves clinical outcome and shortens hospital stay after cancer surgery. J Invest Surg 23:309–313PubMedCrossRef
55.
go back to reference Paccagnella A, Morassutti I, Rosti G (2011) Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol 23:322–330PubMedCrossRef Paccagnella A, Morassutti I, Rosti G (2011) Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol 23:322–330PubMedCrossRef
56.
go back to reference Xue H, Sawyer MB, Wischmeyer PE, Baracos VE (2011) Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. JPEN J Parenter Enteral Nutr 35:74–90PubMedCrossRef Xue H, Sawyer MB, Wischmeyer PE, Baracos VE (2011) Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy. JPEN J Parenter Enteral Nutr 35:74–90PubMedCrossRef
57.
go back to reference Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC (1999) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:80–86PubMedCrossRef Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC (1999) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81:80–86PubMedCrossRef
58.
go back to reference Barber MD, McMillan DC, Preston T, Ross JA, Fearon KC (2000) Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) 98:389–399CrossRef Barber MD, McMillan DC, Preston T, Ross JA, Fearon KC (2000) Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) 98:389–399CrossRef
59.
go back to reference Braga M, Bissolati M, Rocchetti S, Beneduce A, Pecorelli N, Di Carlo V (2012) Oral preoperative antioxidants in pancreatic surgery: a double-blind, randomized, clinical trial. Nutrition 28:160–164PubMedCrossRef Braga M, Bissolati M, Rocchetti S, Beneduce A, Pecorelli N, Di Carlo V (2012) Oral preoperative antioxidants in pancreatic surgery: a double-blind, randomized, clinical trial. Nutrition 28:160–164PubMedCrossRef
60.
go back to reference Liu C, Du Z, Lou C, Wu C, Yuan Q, Wang J, Shu G, Wang Y (2011) Enteral nutrition is superior to total parenteral nutrition for pancreatic cancer patients who underwent pancreaticoduodenectomy. Asia Pac J Clin Nutr 20:154–160PubMed Liu C, Du Z, Lou C, Wu C, Yuan Q, Wang J, Shu G, Wang Y (2011) Enteral nutrition is superior to total parenteral nutrition for pancreatic cancer patients who underwent pancreaticoduodenectomy. Asia Pac J Clin Nutr 20:154–160PubMed
61.
go back to reference Braga M, Gianotti L, Gentilini O, Parisi V, Salis C, Di Carlo V (2001) Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit Care Med 29:242–248PubMedCrossRef Braga M, Gianotti L, Gentilini O, Parisi V, Salis C, Di Carlo V (2001) Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit Care Med 29:242–248PubMedCrossRef
62.
go back to reference van Berge Henegouwen MI, Akkermans LM, van Gulik TM, Masclee AA, Moojen TM, Obertop H, Gouma DJ (1997) Prospective, randomized trial on the effect of cyclic versus continuous enteral nutrition on postoperative gastric function after pylorus-preserving pancreatoduodenectomy. Ann Surg 226:677–685PubMedCrossRef van Berge Henegouwen MI, Akkermans LM, van Gulik TM, Masclee AA, Moojen TM, Obertop H, Gouma DJ (1997) Prospective, randomized trial on the effect of cyclic versus continuous enteral nutrition on postoperative gastric function after pylorus-preserving pancreatoduodenectomy. Ann Surg 226:677–685PubMedCrossRef
63.
go back to reference Mercadante S (1998) Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer 6:85–93PubMedCrossRef Mercadante S (1998) Parenteral versus enteral nutrition in cancer patients: indications and practice. Support Care Cancer 6:85–93PubMedCrossRef
64.
go back to reference Tanjoh K, Tomita R, Mera K, Hayashi N (2002) Metabolic modulation by concomitant administration of insulin and glucagon in pancreatectomy patients. Hepatogastroenterology 49:538–543PubMed Tanjoh K, Tomita R, Mera K, Hayashi N (2002) Metabolic modulation by concomitant administration of insulin and glucagon in pancreatectomy patients. Hepatogastroenterology 49:538–543PubMed
65.
go back to reference Domínguez-Muñoz JE (2011) Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it? Adv Med Sci 56:1–5PubMedCrossRef Domínguez-Muñoz JE (2011) Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it? Adv Med Sci 56:1–5PubMedCrossRef
66.
go back to reference Dobrila Dintinjana R, Guina T, Krznarić Z (2008) Nutritional and pharmacologic support in patients with pancreatic cancer. Coll Antropol 32:505–508PubMed Dobrila Dintinjana R, Guina T, Krznarić Z (2008) Nutritional and pharmacologic support in patients with pancreatic cancer. Coll Antropol 32:505–508PubMed
67.
go back to reference Maskell C, Daniels P, Johnson CD (1999) Dietary intake after pancreatectomy. Br J Surg 86:323–326PubMedCrossRef Maskell C, Daniels P, Johnson CD (1999) Dietary intake after pancreatectomy. Br J Surg 86:323–326PubMedCrossRef
68.
go back to reference Imrie CW, Connett G, Hall RI, Charnley RM (2010) Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther 32(Suppl 1):1–25PubMedCrossRef Imrie CW, Connett G, Hall RI, Charnley RM (2010) Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther 32(Suppl 1):1–25PubMedCrossRef
69.
go back to reference Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM (2005) Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54:540–545PubMedCrossRef Gordon JN, Trebble TM, Ellis RD, Duncan HD, Johns T, Goggin PM (2005) Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54:540–545PubMedCrossRef
70.
go back to reference Yuan XY, Zhang CH, He YL, Yuan YX, Cai SR, Luo NX, Zhan WH, Cui J (2008) Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery? A prospective randomized controlled trial. Am J Surg 196:751–755PubMedCrossRef Yuan XY, Zhang CH, He YL, Yuan YX, Cai SR, Luo NX, Zhan WH, Cui J (2008) Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery? A prospective randomized controlled trial. Am J Surg 196:751–755PubMedCrossRef
Metadata
Title
Nutritional Status and Nutritional Support Before and After Pancreatectomy for Pancreatic Cancer and Chronic Pancreatitis
Authors
Vasiliki Th. Karagianni
Apostolos E. Papalois
John K. Triantafillidis
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Indian Journal of Surgical Oncology / Issue 4/2012
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-012-0189-4

Other articles of this Issue 4/2012

Indian Journal of Surgical Oncology 4/2012 Go to the issue